McKesson Corporation

MCK.US
Healthcare · Medical Distribution
889.50
+39.44 (+4.64%)
USD · NYSE

Company Information

Company Name
McKesson Corporation
Sector
Healthcare
Industry
Medical Distribution
Exchange
NYSE
ISIN: US58155Q1031
CIK: 0000927653
CUSIP: 581557105
Currency: USD
Full Time Employees: 41,600
Phone: 972 446 4800
Fiscal Year End: March
IPO Date: Nov 15, 1994
Description:

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Address:

6555 State Highway 161, Irving, TX, United States, 75039

People

Directors & Officers

Name Title Year Born
Mr. Brian S. Tyler Ph.D. CEO & Chairman 1967
Ms. Michele Lau J.D. Executive VP & Chief Legal Officer 1976
Ms. LeAnn B. Smith Executive VP & Chief Human Resources Officer 1975
Mr. Thomas L. Rodgers M.B.A. Executive VP and Chief Strategy & Business Development Officer 1971
Mr. Kenny K. Cheung Executive VP & CFO 1982
Mr. Napoleon B. Rutledge Jr. Senior VP, Controller & Chief Accounting Officer 1973
Mr. Francisco J. Fraga Executive VP, Chief Information Officer & CTO 1973
Ms. Jeni Dominguez Head of Investor Relations NA
Mr. Kirk Kaminsky Executive VP & Group President of North American Pharmaceutical Services NA
Paul A. Smith Senior Vice President of Taxes NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 23, 2026 Ro Khanna N/A Sale N/A $878.61 N/A
Mar 02, 2026 Michele Lau N/A Sale 2.73K $990.00 $2.70M
Feb 24, 2026 Ro Khanna N/A Purchase N/A $957.77 N/A
Feb 19, 2026 Maria Martinez N/A Sale 349.00 $939.87 $328.01K
Feb 17, 2026 Leann B Smith N/A Sale 190.00 $945.00 $179.55K
Feb 06, 2026 Napoleon B Rutledge Jr N/A Sale 328.00 $955.00 $313.24K
Feb 04, 2026 Markwayne Mullin N/A Purchase N/A $819.58 N/A
Jan 05, 2026 Thomas L Rodgers N/A Sale 276.00 $816.18 $225.27K
Jan 05, 2026 Markwayne Mullin N/A Purchase N/A $823.96 N/A
Dec 19, 2025 Gilbert Ray Cisneros, Jr. N/A Sale N/A $819.92 N/A
Dec 02, 2025 Jared Moskowitz N/A Purchase N/A $829.44 N/A
Nov 18, 2025 Gilbert Ray Cisneros, Jr. N/A Purchase N/A $861.33 N/A
Nov 07, 2025 Napoleon B Rutledge Jr N/A Sale 329.00 $861.63 $283.48K
Nov 03, 2025 Ro Khanna N/A Purchase N/A $820.42 N/A
Oct 08, 2025 Jonathan L. Jackson N/A Sale N/A $755.32 N/A
Sep 29, 2025 Ro Khanna N/A Sale N/A $762.22 N/A
Sep 23, 2025 Val T. Hoyle N/A Sale N/A $739.48 N/A
Sep 10, 2025 Val T. Hoyle N/A Purchase N/A $705.88 N/A
Aug 22, 2025 Brian S Tyler N/A Sale 11.93K $705.63 $8.42M
Aug 15, 2025 Brian S Tyler N/A Sale 11.93K $677.76 $8.09M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 12.10M Dec 31, 2025 10.34% $0.14 0.61%
BlackRock Inc 11.42M Mar 31, 2026 9.75% $0.17 -0.61%
Vanguard Capital Management, LLC 7.96M Mar 31, 2026 6.80% $0.17 0.00%
State Street Corp 5.73M Mar 31, 2026 4.90% $0.17 -0.84%
FMR Inc 3.60M Mar 31, 2026 3.08% $0.16 12.43%
JPMorgan Chase & Co 3.27M Mar 31, 2026 2.79% $0.18 26.23%
Franklin Resources Inc 3.06M Mar 31, 2026 2.62% $0.65 8.39%
Geode Capital Management, LLC 2.90M Mar 31, 2026 2.48% $0.16 1.63%
Massachusetts Financial Services Company 2.90M Mar 31, 2026 2.48% $0.85 -15.84%
Vanguard Portfolio Management, LLC 2.88M Mar 31, 2026 2.46% $0.13 0.00%
Morgan Stanley - Brokerage Accounts 2.30M Mar 31, 2026 1.96% $0.12 -3.75%
AllianceBernstein L.P. 2.24M Mar 31, 2026 1.91% $0.60 -9.89%
NORGES BANK 2.01M Dec 31, 2025 1.72% $0.18 9.53%
Bank of America Corp 1.54M Mar 31, 2026 1.31% $0.10 2.39%
Amvescap Plc. 1.49M Mar 31, 2026 1.27% $0.13 41.69%
Northern Trust Corp 1.46M Mar 31, 2026 1.25% $0.17 -1.88%
Arrowstreet Capital Limited Partnership 1.31M Mar 31, 2026 1.12% $0.61 -4.66%
The Goldman Sachs Group Inc 1.31M Mar 31, 2026 1.11% $0.13 40.84%
Royal Bank of Canada 1.28M Mar 31, 2026 1.10% $0.19 -10.93%
Boston Partners Global Investors, Inc 1.16M Mar 31, 2026 0.99% $1.05 -6.07%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.82M 3.26% ▼ 2.08% Jun 30, 2026
2 Vanguard 500 Index Investor 3.12M 2.67% ▼ 2.66% Jun 30, 2026
3 iShares Core S&P 500 ETF 1.66M 1.42% ▲ 0.32% Jun 30, 2026
4 MFS Large Cap Value Equity 1.65M 1.41% ▼ 18.77% Mar 31, 2026
5 Fidelity 500 Index 1.57M 1.34% ▼ 0.14% May 31, 2026
6 State Street® SPDR® S&P 500® ETF 1.45M 1.24% ▼ 1.29% Jun 30, 2026
7 MFS Value A 1.43M 1.22% ▼ 8.54% Jun 30, 2026
8 Putnam Large Cap Value A 1.23M 1.05% ▲ 0.00% Jun 30, 2026
9 JPMorgan Large Cap Growth I 1.20M 1.03% ▼ 10.85% May 31, 2026
10 Vanguard Value Index Inv 1.14M 0.98% ▲ 0.04% Jun 30, 2026

Financial Highlights

Market Cap: $104.14B
EBITDA: $6.88B
P/E Ratio: $22.17
PEG Ratio: $1.66
Book Value: $-18.10
Dividend/Share: $3.17
Dividend Yield: 0.37%
Earnings/Share: $40.12
Profit Margin: 1.18%
Operating Margin: 2.21%
ROA (TTM): 4.99%
ROE (TTM): 0.00%
Revenue (TTM): $403.43B
Revenue/Share (TTM): $3.26K
Earnings Growth (YOY): 37.20%
Revenue Growth (YOY): 6.00%

Valuation Metrics

Enterprise Value: $108.78B
Trailing P/E: 22.17
Forward P/E: 19.19

Shares Statistics

Shares Outstanding: 117.08M
Shares Float: 120.01M
% Insiders: 5.20%
% Institutions: 9,532.00%
Short % Float: 3.31%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$403.43B
Cost of Goods Sold
adjust
$-388.88B
Gross Profit
subtotal
$14.55B
SG&A
adjust
$-8.10B
R&D
adjust
$-103.00M
Operating Income
subtotal
$6.45B
Other / Non-Operating Items
adjust
$-1.69B
Net Income
subtotal
$4.76B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MCK.US!